MIR146B and central nervous system cancer: Contrarily, the hypermethylation and down-expression of MIR146B were reported in diffuse and anaplastic astrocytomas, gliomas, and breast cancer being the 5-AZA-dC treatment capable to induce the MIR146B expression [23, 24].